(Q43680450)

25 November 2017

title

Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptor (English)

1 reference

25 November 2017

G Vauquelin

1

1 reference

25 November 2017

F Fierens

series ordinal

2

1 reference

25 November 2017

I Verheijen

series ordinal

3

1 reference

25 November 2017

P Vanderheyden

series ordinal

4

1 reference

25 November 2017

publication date

1 July 2001

1 reference

Trends in Pharmacological Sciences

25 November 2017

published in

1 reference

25 November 2017

volume

22

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

343-344

1 reference

Dynamic mechanisms of non-classical antagonism by competitive AT(1) receptor antagonists

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Non-surmountable antagonism: a general drawback of pre-steady-state measurement?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Distinctions between non-peptide angiotensin II AT1-receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901739-9

7 January 2021

10.1016/S0165-6147(00)01739-9

Identifiers

DOI

1 reference

25 November 2017

1 reference